SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Harmon who wrote (1029)2/10/1998 1:29:00 PM
From: Rudy Saucillo  Read Replies (3) of 2742
 
I'm as frustrated as anyone about the lack of visible progress by BlueStone. But given the financial incentives of their contract, I find it hard to believe they're not doing *something*. Using your numbers, Steve, and assuming all warrants have a strike price of 25 cents, BlueStone could make a quick $1+ million if they simply sold the company for fair value. Given all CIST's cash and their lock on IL-1b, it shouldn't be hard to do. A potential $1 million windfall would certainly motivate *me* to get on the horn and cut a deal!

It'll be interesting to see if the BlueStone contract is extended this month. Also looking forward to the periodontal longitudinal study results and the 10Q due out in a few days.

Rudy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext